Nicole Foley, MD

Co-Chief Fellow

Hometown: Rancho Palos Verdes, California

Medical School: Western Michigan University Stryker School of Medicine

Residency: Washington University School of Medicine / Barnes Jewish Hospital

Research/Academic Interests: clinical and translational research on hematologic malignancies, bone marrow transplantation, graft versus host disease, cellular and immuno-therapies

Bio: When I’m not working and the weather permits, I enjoy spending time outside. The fall months are the best for hiking in local parks or biking on the Katy trail. Another great source of entertainment for me is live music which sadly, but necessarily, was on hiatus during COVID. From classical orchestra music to bluegrass, all types of concerts enable me to live in the moment.

Selected Publications/Abstracts

Foley, N.C., Mehta-Shah, N. Management of Peripheral T-cell Lymphomas and the Role of Transplant. Current Oncology Reports. August 2022. PMID: 35947286
Roloff, G.W., Odenike, O., Bajel, A., Wei, A., Foley, N., Uy, G. Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022. American Society of Clinical Oncology Educational Book 2022:42, 1-16. PMID: 35658497
Goldsmith S.R., Foley N.C., Schroeder M.A. Daratumumab for the Treatment of Multiple Myeloma. Drugs Today (Barc). October 2021. PMID: 34713868
Foley, N.C., Fiala, M.A., Zweegman, S., Vij, R., & Wildes, T.M. The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma. Journal of Geriatric Oncology. November 2020. PMID: 32169544
Foley, N.C., Van Ziffle, J., Yu, J., Qi, Z., Grenert, J., Yeh, I., Bastain, B., Kogan, S., & Mannis, G.N. Acute Myeloid Leukemia with t(14;21) Involving RUNX1 and SYNE2: A Novel Favorable-Risk Translocation? Cancer Genetics. October 2017. PMID: 29025598
Foley, N.C., Bystrom, P., Toledo-Pereyra, L., Quesnelle, K. Ischemic preconditioning modulates ROS to confer protection in liver ischemia and reperfusion. EXCLI Journal. April 7, 2017. PMID: 28694752